calpeptin has been researched along with Multiple Sclerosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azuma, M; Banik, NL; Chauhan, A; Das, A; Hogan, EL; Inoue, J; Nozaki, K; Podbielska, M; Ray, SK; Smith, AW | 1 |
| Banik, NL; Butler, JT; Das, A; Guyton, MK; Ray, SK; Samantaray, S; Wallace, GC | 1 |
| Banik, NL; Guyton, MK; Haque, A; Imam, SA; Ray, SK; Tyor, WR; Vandenbark, A | 1 |
3 other study(ies) available for calpeptin and Multiple Sclerosis
| Article | Year |
|---|---|
Neuron-microglia interaction induced bi-directional cytotoxicity associated with calpain activation.
Topics: Animals; Calpain; Carbamates; Cell Survival; Cysteine Proteinase Inhibitors; Dipeptides; Enzyme Activation; Gene Knockdown Techniques; Humans; Inflammation; Microglia; Motor Neurons; Multiple Sclerosis; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Th1 Cells; Th17 Cells | 2016 |
Calpeptin attenuated inflammation, cell death, and axonal damage in animal model of multiple sclerosis.
Topics: Animals; Axons; Blotting, Western; Calpain; Cell Death; Cysteine Proteinase Inhibitors; Dipeptides; Down-Regulation; Encephalomyelitis, Autoimmune, Experimental; Fluorescent Antibody Technique; Gliosis; In Situ Nick-End Labeling; Inflammation; Male; Multiple Sclerosis; Nerve Tissue Proteins; Oligodendroglia; Rats; Rats, Inbred Lew; Spinal Cord; Tissue Embedding | 2010 |
Increased calpain correlates with Th1 cytokine profile in PBMCs from MS patients.
Topics: Biomarkers; Calcium; Calcium Signaling; Calpain; Cytokines; Dipeptides; Enzyme Inhibitors; Female; Humans; Male; Multiple Sclerosis; Myelin Basic Protein; Neutrophils; Recurrence; Th1 Cells; Th2 Cells; Up-Regulation | 2007 |